Medications

More biosimilars marketed in Germany, Switzerland than U.S.

More biosimilars have been marketed in Germany and Switzerland than in the United States, but uptake has increased over time in all countries, according to a study published online Dec. 2 in JAMA Network Open.

Medications

Smarter prescriptions from doctors could save NHS billions

GP's could save billions of pounds for the NHS by switching patients' prescriptions from patented medicine to alternative drugs whose patent has expired, a new study shows. Researchers found that whilst some practitioners ...

Medications

US: 'Pay to delay' generic drugs can be illegal (Update)

The Supreme Court ruled Monday that deals between pharmaceutical corporations and their generic drug competitors, which government officials say keep cheaper forms of medicine off the market, can be sometimes be illegal and ...

Medications

J&J and other drugmakers go on trial over US opioid crisis

Drugmakers including Johnson & Johnson on Tuesday denied claims they helped fuel the deadly opioid epidemic in the United States through deceptive marketing that downplayed addiction risks, as the trial in a lawsuit filed ...

Medications

India probes charges of violations by drugs regulator

India's Health Ministry said Thursday it was examining charges that the government's top drug regulatory agency had colluded with pharmaceutical firms to approve drugs without proper clinical trials.

page 8 from 14